NorthWest Biotherapeutics Inc (NWBO)

[skitahoe]

As much as I'd love to see the unblinded data, barring that, I would like to see an update by Dr. Liau on what she previously reported, the Top 100. In that group it was clear that the median was growing and was near 60 months at the time, it's clear that many in the Top 100 are still alive, and that median is now well above 60 months. Clearly Dr. Liau does have access to all this information as she previously reported on it, so an update could be made. She has previously reported on how many in the trial remained alive, so that's something that can be brought up to date and reported again.

If the SAP is acceptable to all 4 regulators I believe we're in the process of unblinding, but if not, the delay will be until we have that agreement, or a determination is made to limit the regulators that initial approval would be made with. While the hang up, if there is one, is probably the U.S. FDA, which represents the biggest market, if in fact they're unwilling to make the necessary changes, it wouldn't be the first time great drugs were initially approved elsewhere, and the FDA finally went along.

I do believe that things are coming to a head, by the time of the Annual Meeting we'll know more, but what we'll know will be up to the company.

Gary